This review aims to summarize the landscape of therapies that are currently being tested or planned in patients with idiopathic inflammatory myopathies (IIM), emphasizing a variety of clinical trials focused on mitigating the progression of these conditions.
Recent Findings
Novel therapies for IIM are evolving, with recent studies highlighting several promising approaches.
Summary
This shift will outline the advancements achieved thus far in the treatment of IIM.
